Product Description
Carmellose sodium is a lubricant used to treat dry eyes. It comes as eye drops that work like artificial tears. They soothe dry eyes and make them feel moist again. (Sourced from: https://www.nhs.uk/medicines/carmellose-sodium/)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Subcutaneous,Topical,Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Argentina | Austria | Bangladesh | Brazil | Chile | Colombia | Denmark | Dominican Republic | Egypt | Finland | France | Germany | Hong Kong | India | Indonesia | Ireland | Italy | Korea | Mexico | Morocco | Netherlands | New Zealand | Pakistan | Philippines | Portugal | South Africa | Spain | Sri Lanka | Taiwan | Thailand | Tunisia | Turkey | United Arab Emirates | United Kingdom | Uruguay | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: AbbVie
Company Location: NORTH CHICAGO IL 60064
Company CEO: Richard A. Gonzalez
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 4: Dry Eye Syndromes|Cesarean Section|Keratoconjunctivitis Sicca|Cataract|Intestinal Cancer|Prostate Cancer|Other|Intestinal Obstruction|Conjunctivitis
Phase 3: Keratoconjunctivitis Sicca|Dry Eye Syndromes|Dry Eye Disease|Other|Colorectal Cancer
Phase 2: Triple Negative Breast Cancer
Phase 1: Glioma
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| NCI-2024-00210 | P1 |
Recruiting |
Glioma |
2027-03-08 |
|
| 2024-513778-23-00 | P3 |
Unknown Status |
Colorectal Cancer |
2026-07-31 |
|
| NCI-2018-01581 | P2 |
Recruiting |
Triple Negative Breast Cancer |
2025-11-30 |
|
| COC-R4-CMC | N/A |
Completed |
Keratoconjunctivitis Sicca|Dry Eye Disease|Dry Eye Syndromes |
2022-07-29 |